Resources

BIOVECTRA offers a number of resources to help keep you up to date on industry trends and activities. Meet with us at events, follow us on LinkedIn, and explore the following resources for educational content.

  • Categories

Computer screen displaying an article on pharmaceutical technology with sections for news, publications, and resources. Advertisement banners are visible on the side.

Article

Validating the effectiveness of the cleaning of pharmaceutical manufacturing and process equipment is part of good manufacturing practices (GMPs) (1,2). Regulators expect manufacturers to be able to […]

A desktop computer displaying a webpage from PharmTech. The article discusses operational excellence in the biopharmaceutical industry, featuring related advertisements and navigation menus.

Article

Operational excellence relies heavily on an organization being staffed with the adequate amount of properly trained personnel. The pharmaceutical industry has seen an increase in new modalities […]

A computer monitor displays a webpage from BioPharm International, featuring articles and advertisements related to biologics and pharmaceuticals.

Article

The COVID-19 pandemic put a spotlight on how the bio/pharmaceutical industry and regulators can work together to bring life-saving therapies to the market fast to safeguard and improve public health. The lessons learned […]

A computer monitor displays an article about chemistry services, featuring industrial machinery with stainless steel equipment, published by Pharma's Almanac.

Article

The most effective contract development and manufacturing organizations (CDMOs) help their clients by developing optimal, cost-efficient processes. Since its origins over 50 years ago, BIOVECTRA has […]

A computer screen displays an article from PharmaTech about the role of Certificates of Analysis in supplier oversight, with highlighted text and advertisements.

Article

Certificates of analysis (CoAs) are used by materials suppliers to identify the product they are providing to a pharmaceutical manufacturer. They include information such as product name, material grade, batch number, expiration dates, testing dates, information on analytical […]

A computer screen displays a BioPharm International article titled “Weighing the Benefits of Fermentation for New Biotherapies,” highlighting industry insights.

Article

Microbial fermentation has its place in the biomanufacturing industry, despite the prevalence of mammalian-based cell culture processes for the production of biologics. However, despite the lower costs and potential for substantial product […]

A person displayed on a computer screen; webpage discusses supply issues in cell and gene therapies, emphasizing GMP-grade plasmid DNA.

Article

Perhaps the biggest supply issue for cell and gene therapies is a lack of reliable sources of GMP-grade plasmid DNA. The supply of pDNA – and, therefore, mRNA – is constrained by both manufacturing issues and short supply of consumables […]

A computer screen displays a webpage from Drug Discovery & Development featuring an article about a company's chief commercial officer's role in success.

Article

Two decades ago, the Canadian CDMO BioVectra installed Heather Delage as its director of business development. She was named vice president of business development […]

Computer monitor displaying a Pharmaceutical Technology article. Topics include API quality, analytical methods, and manufacturing. Features logos and a yellow hiring ad.

Article

Effective and safe APIs provide the necessary element of drugs to treat patients with a variety of health conditions. It is, therefore, crucial that the quality of APIs, along with other ingredients that make up a medicine […]

A computer monitor displays an article about BioVectra's mRNA biomanufacturing expansion ambitions, highlighting plans and investments in manufacturing facilities in Canada.

Article

Founded in 1970, BIOVECTRA is a CDMO with specialties in microbial fermentation, complex chemistry and biologics. The company is looking to bolster its mRNA manufacturing capability.[…]

A computer screen displays an article about BioVectra's growth and battery technology innovations, featuring a person and images of batteries.

Article

Headquartered in Atlantic Canada, BIOVECTRA is a heavyweight global CDMO with a rich history and relentless focus on adapting to future trends. With an eye on the next generation of pharmaceuticals […]

A computer monitor displays the website "Drug Development & Delivery," featuring articles, advertisements, and an interview. No recognizable landmarks or historical buildings are present.

Interview

When Dr. Marc Sauer joined BIOVECTRA as a research scientist in 2006, the company of 60 was focused on small molecules and microbial fermentation. Today, at just shy of 600 employees, BIOVECTRA is a […]

SEO plus – Test

  • 20+ years at GSK, leading R&D activities on multiple vaccine programs
  • Recently held positions in industry include: Senior Director (Function Head), Protein Biochemistry; Director, Antigen Design & Prototype Production; and, Associate Director, Antigen Design and Protein Characterization.
  • Key areas of expertise are:
    • Process development of protein Biologics/Recombinant Antigens
    • Recombinant protein expression (mammalian, insect, yeast, bacterial)
    • Production/design of Viral Vectors, mRNA vaccines, Bacterial outer membrane vesicles
    • Protein Engineering and Structural Biology
    • Defining quality attributes, biophysical characterization of proteins, and analytical strategy
  • Post graduate degrees in Functional Genomics (Université Laval) and Bioinformatics (MIT); M. Sc. Microbiology and Immunology (Laval).
  • 25+ Patent & 5 Scientific Publications

Normand Blais – Senior Director Development & Innovation, Biologics

  • 20+ years at GSK, leading R&D activities on multiple vaccine programs
  • Recently held positions in industry include: Senior Director (Function Head), Protein Biochemistry; Director, Antigen Design & Prototype Production; and, Associate Director, Antigen Design and Protein Characterization.
  • Key areas of expertise are:
    • Process development of protein Biologics/Recombinant Antigens
    • Recombinant protein expression (mammalian, insect, yeast, bacterial)
    • Production/design of Viral Vectors, mRNA vaccines, Bacterial outer membrane vesicles
    • Protein Engineering and Structural Biology
    • Defining quality attributes, biophysical characterization of proteins, and analytical strategy
  • Post graduate degrees in Functional Genomics (Université Laval) and Bioinformatics (MIT); M. Sc. Microbiology and Immunology (Laval).
  • 25+ Patent & 5 Scientific Publications

Oliver Technow - Chief Executive Officer

  • Industry Master Degree from Frankfurt Chamber of Commerce, Frankfurt Germany.
  • More than 20 years of global pharmaceutical industry experience.
  • Held numerous leadership positions in commercial development, marketing and brand management, and lifecycle management and has extensive product launch and market access expertise in Europe and North America.
  • In 1997, joined Eisai GmbH in Frankfurt, Germany and in 2002, was appointed Director, CNS Business Unit; in 2006, was appointed Vice President, Head of Global Marketing for Eisai Inc. in Woodcliff Lake, NJ;  in 2011, was appointed Vice President, Established Products Business Unit; in 2013, was appointed President & General Manager for Eisai Limited in Mississauga, ON.
  • Appointed President of BIOVECTRA Inc., December 10, 2015.
  • Board Director for BIOTECanada
  • Member of the Steering Council of Innovative Medicines Canada (IMC)
  • In 2017, appointed to the Government of Canada’s Health/Bio-sciences Strategic Economic Table
  • In November 2019, promoted to Chief Executive Officer at BIOVECTRA
  • In June 2020, named new Chair of PEI BioAlliance Board of Directors